Study to Compare How the Body Distributes and Excretes the Drugs Jivi (BAY 94-9027) and Adynovi in Patients With Severe Hemophilia A (Bleeding Disorder Resulting From a Lack of Blood Clotting Factor VIII)

Condition:   Hemophilia A Interventions:   Biological: Damoctocog-alfa-pegol (BAY94-9027, Jivi);   Biological: Rurioctocog alfa pegol (Adynovi) Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials